Skip to main content

Lineage Cell Therapeutics, Inc.

LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000876343

No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Lineage Cell Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
124
+9 vs. Q3 2021
Shares held
74.4M
−1.45M (−1.9%) vs. Q3 2021
Total value
$182.0M
−$9.76M (−5.1%) vs. Q3 2021
New holders
25
27 more added
Sold out
16
39 more reduced

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 124 institutions
Q1 2021: 102 institutionsQ2 2021: 115 institutionsQ3 2021: 115 institutionsQ4 2021: 124 institutionsQ1 2022: 109 institutionsQ2 2022: 100 institutionsQ3 2022: 104 institutionsQ4 2022: 106 institutionsQ1 2023: 116 institutionsQ2 2023: 107 institutionsQ3 2023: 104 institutionsQ4 2023: 115 institutionsQ1 2024: 116 institutionsQ2 2024: 113 institutionsQ3 2024: 114 institutionsQ4 2024: 126 institutionsQ1 2025: 127 institutionsQ2 2025: 129 institutionsQ3 2025: 112 institutionsQ4 2025: 123 institutionsQ1 2026: 130 institutionsQ2 2026: 131 institutions
Value heldQ4 2021: $182.0M
Q1 2021: $141.8MQ2 2021: $208.5MQ3 2021: $191.7MQ4 2021: $182.0MQ1 2022: $112.3MQ2 2022: $102.7MQ3 2022: $73.1MQ4 2022: $76.2MQ1 2023: $104.7MQ2 2023: $106.6MQ3 2023: $89.1MQ4 2023: $82.5MQ1 2024: $138.3MQ2 2024: $94.2MQ3 2024: $85.6MQ4 2024: $53.8MQ1 2025: $49.7MQ2 2025: $88.4MQ3 2025: $148.6MQ4 2025: $169.8MQ1 2026: $176.5MQ2 2026: $152.7M
Institutions holding LCTX and their total value by quarter
QuarterHoldersValue
Q2 2026131$152.7M
Q1 2026130$176.5M
Q4 2025123$169.8M
Q3 2025112$148.6M
Q2 2025129$88.4M
Q1 2025127$49.7M
Q4 2024126$53.8M
Q3 2024114$85.6M
Q2 2024113$94.2M
Q1 2024116$138.3M
Q4 2023115$82.5M
Q3 2023104$89.1M
Q2 2023107$106.6M
Q1 2023116$104.7M
Q4 2022106$76.2M
Q3 2022104$73.1M
Q2 2022100$102.7M
Q1 2022109$112.3M
Q4 2021124$182.0M
Q3 2021115$191.7M
Q2 2021115$208.5M
Q1 2021102$141.8M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding LCTX in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Albion Financial Group3,043$7.00K0.00%00.0%Unchanged
Pacifica Partners Inc.2,926$6.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.2,284$5.00K0.00%−89−3.8%Reduced
Reilly Financial Advisors, LLC2,000$5.00K0.00%00.0%Unchanged
O'Dell Group, LLC2,000$5.00K0.00%00.0%Unchanged
TCI Wealth Advisors, Inc.2,137$5.00K0.00%+2,137New
Concord Wealth Partners1,500$4.00K0.00%00.0%Unchanged
Lindbrook Capital, LLC1,754$4.00K0.00%+1,725+5,948.3%Added
Fifth Third Bancorp1,420$3.00K0.00%00.0%Unchanged
Archer Investment Corp1,000$2.45K0.00%00.0%Unchanged
Captrust Financial Advisors678$2.00K0.00%00.0%Unchanged
Chilton Capital Management LLC400$1.00K0.00%+400New
Bivin & Associates, Inc.600$1.00K0.00%+600New
Central Trust Co29$00.00%00.0%Unchanged
FMR LLC2$00.00%00.0%Unchanged
First Manhattan Co94$00.00%00.0%Unchanged
Focused Wealth Management, Inc8$00.00%00.0%Unchanged
Meeder Asset Management Inc5$00.00%+5New
National Bank of Canada14$00.00%+14New
CWM, LLC35$00.00%+35New
Cribstone Capital Management, LLC88$00.00%+88New
Amplius Wealth Advisors, LLC29$00.00%+29New
Comprehensive Financial Consultants Institutional, Inc.5$00.00%+5New
CoreCap Advisors, LLC2––+2New
Bank of Montreal0$00.00%−359,381−100.0%Sold out
Rafferty Asset Management, LLC0$00.00%−193,756−100.0%Sold out
Laidlaw Wealth Management LLC0$00.00%−104,841−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−96,762−100.0%Sold out
Winton Group Ltd0$00.00%−62,869−100.0%Sold out
Thrivent Financial for Lutherans0$00.00%−42,533−100.0%Sold out
Sightline Wealth Advisors, LLC0$00.00%−14,958−100.0%Sold out
Group One Trading, L.P.0$00.00%−13,807−100.0%Sold out
IFP Advisors, Inc0$00.00%−11,077−100.0%Sold out
E Fund Management Co., Ltd.0$00.00%−11,095−100.0%Sold out
Glen Eagle Advisors, LLC0$00.00%−500−100.0%Sold out
Godsey & Gibb Associates0$00.00%−500−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−396−100.0%Sold out
Community Bank, N.A.0$00.00%−508−100.0%Sold out
Assetmark, Inc0$00.00%−9−100.0%Sold out
Gerber Kawasaki Wealth & Investment Management0$00.00%−1−100.0%Sold out